<DOC>
	<DOCNO>NCT02543970</DOCNO>
	<brief_summary>The primary objective study confirm safe effective use Celluma3 reduction appearance periorbital wrinkle .</brief_summary>
	<brief_title>A Confirmatory Study Evaluation Treatment Celluma3 Periorbital Wrinkles</brief_title>
	<detailed_description>This clinical study open label investigation use Celluma3 effective treatment periorbital wrinkle . Test subject visit study center thirty minute treatment , three time per week , period four week , twelve week post-treatment follow final treatment . Test subject photo take start , end four week treatment , final twelve week post-treatment follow visit . One three Clinical Investigators , act Principal Investigator three Clinical Investigators evaluate test subject inclusion final result . The Clinical Research Associate ( CRA ) monitor study conformance test protocol . There seven esthetician participate study fifty test subject recruit .</detailed_description>
	<criteria>1 . 3075 year age 2 . Fitzpatrick Skin Color Type IIV 3 . Clinical evidence mild moderate facial wrinkle specify Fitzpatrick Classification Facial Wrinkling ( Perioral Periorbital ) degree wrinkle elastosis . 4 . Willingness ability comply protocol requirement , include return follow visit abstain excluded behavior duration study . 5 . Willingness ability provide write consent use photographic record adherence photographic procedure ( i.e. , removal makeup jewelry ) . 6 . Willingness ability provide write informed consent prior studyrelated procedure . 7 . Absence exclusionary criterion 1 . Subject pregnant , nursing , plan become pregnant course study . 2 . Subjects history diabetes . 3 . Subjects , precede 12 month prior study start , : 1 . Been expose hyaluronic acid , 2. filler , 3. injection cosmetic purpose related face , 4. undergone cosmetic procedure face , 5. active cut , wound infection face , 6. oral isotretinon . 4 . Subjects , precede six month prior study start , : 1 . Had botulinum toxin ( `` Botox '' ) , 2. ablative skin resurface glabellar area . 5 . Subjects , precede three month prior study start , : 1 . Had retinoid , microdermabrasion prescription level glycolic acid treatment , 2. compromise procedure opinion clinical evaluator . 6 . Any diagnosis contraindication current User Manual .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>